Evidence map›Paper›PMID 34654803›Full record

ArticleNature communications2021

Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice.

Gwynne L Davis, Adelaide R Minerva, Argentina Lario, Linda D Simmler, Carolyn I Rodriguez, Lisa A Gunaydin

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Acute (Frontiers in neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gwynne L DavisInstitute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
Adelaide R MinervaInstitute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
Argentina LarioInstitute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
Linda D SimmlerDepartment of Basic Neurosciences, University of Geneva, Rue Michel-Servet 1, 1206, Geneva, Switzerland.
Carolyn I RodriguezDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Lisa A GunaydinInstitute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA. lisa.gunaydin@ucsf.edu.ORCID 0000-0001-7420-4784
University of California, San Francisco · USUniversity of Geneva · CHVA Palo Alto Health Care System · US

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
NMDAR Modulation As A Therapeutic Target and Probe of Neural Dysfunction in OCDR01MH105461 · NIMH · STANFORD UNIVERSITY · PI RODRIGUEZ, CAROLYN I · 2015 to 2020
$4.2M
NCATS NIH HHS UL1 TR001872NIMH NIH HHS R01 MH105461
6 · The paper itself

Abstract

Obsessive-Compulsive Disorder (OCD), characterized by intrusive thoughts (obsessions) and repetitive behaviors (compulsions), is associated with dysfunction in fronto-striatal circuits. There are currently no fast-acting pharmacological treatments for OCD. However, recent clinical studies demonstrated that an intravenous infusion of ketamine rapidly reduces OCD symptoms. To probe mechanisms underlying ketamine's therapeutic effect on OCD-like behaviors, we used the SAPAP3 knockout (KO) mouse model of compulsive grooming. Here we recapitulate the fast-acting therapeutic effect of ketamine on compulsive behavior, and show that ketamine increases activity of dorsomedial prefrontal neurons projecting to the dorsomedial striatum in KO mice. Optogenetically mimicking this increase in fronto-striatal activity reduced compulsive grooming behavior in KO mice. Conversely, inhibiting this circuit in wild-type mice increased grooming. Finally, we demonstrate that ketamine blocks the exacerbation of grooming in KO mice caused by optogenetically inhibiting fronto-striatal activity. These studies demonstrate that ketamine increases activity in a fronto-striatal circuit that causally controls compulsive grooming behavior, suggesting this circuit may be important for ketamine's therapeutic effects in OCD.

Indexed as

AnimalsCompulsive BehaviorCorpus StriatumDisease Models, AnimalFemaleGroomingHumansKetamineMaleMiceMice, Inbred C57BLMice, KnockoutNeostriatumNerve Tissue ProteinsNeuronsObsessive-Compulsive DisorderKetamineNerve Tissue ProteinsSapap3 protein, mouse

Identifiers

PMID34654803
PMCPMC8519915
OpenAlexW3207955451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.